[go: up one dir, main page]

DE69735603D1 - PTHrP Analogen - Google Patents

PTHrP Analogen

Info

Publication number
DE69735603D1
DE69735603D1 DE69735603T DE69735603T DE69735603D1 DE 69735603 D1 DE69735603 D1 DE 69735603D1 DE 69735603 T DE69735603 T DE 69735603T DE 69735603 T DE69735603 T DE 69735603T DE 69735603 D1 DE69735603 D1 DE 69735603D1
Authority
DE
Germany
Prior art keywords
pthrp
pthrp analogues
parathyroid hormone
analogues
pth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69735603T
Other languages
English (en)
Other versions
DE69735603T2 (de
Inventor
Xin Dong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/779,768 external-priority patent/US5969095A/en
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Application granted granted Critical
Publication of DE69735603D1 publication Critical patent/DE69735603D1/de
Publication of DE69735603T2 publication Critical patent/DE69735603T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE69735603T 1997-01-07 1997-12-08 PTHrP Analogen Expired - Lifetime DE69735603T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/779,768 US5969095A (en) 1995-07-13 1997-01-07 Analogs of parathyroid hormone
US779768 1997-01-07
US08/813,534 US5955574A (en) 1995-07-13 1997-03-07 Analogs of parathyroid hormone
US813534 1997-03-07
PCT/US1997/022498 WO1998030590A2 (en) 1997-01-07 1997-12-08 Analogs of parathyroid hormone

Publications (2)

Publication Number Publication Date
DE69735603D1 true DE69735603D1 (de) 2006-05-18
DE69735603T2 DE69735603T2 (de) 2006-11-30

Family

ID=27119618

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69735603T Expired - Lifetime DE69735603T2 (de) 1997-01-07 1997-12-08 PTHrP Analogen
DE69739912T Expired - Lifetime DE69739912D1 (de) 1997-01-07 1997-12-08 Parathyroidhormon Analoge

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69739912T Expired - Lifetime DE69739912D1 (de) 1997-01-07 1997-12-08 Parathyroidhormon Analoge

Country Status (23)

Country Link
US (1) US5955574A (de)
EP (3) EP0948541B1 (de)
JP (1) JP3963482B2 (de)
KR (2) KR100497709B1 (de)
CN (1) CN1137898C (de)
AR (3) AR011517A1 (de)
AT (2) ATE471342T1 (de)
AU (1) AU741584B2 (de)
BR (1) BR9714200A (de)
CA (1) CA2276614C (de)
CZ (2) CZ301497B6 (de)
DE (2) DE69735603T2 (de)
DK (2) DK0948541T3 (de)
ES (2) ES2258286T3 (de)
HU (1) HUP9904596A3 (de)
IL (1) IL130794A0 (de)
NO (1) NO993341L (de)
NZ (1) NZ336610A (de)
PL (1) PL191898B1 (de)
PT (2) PT948541E (de)
RU (1) RU2198182C2 (de)
SI (2) SI0948541T1 (de)
WO (1) WO1998030590A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7410948B2 (en) * 1995-07-13 2008-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Analogs of parathyroid hormone
US6544949B1 (en) * 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
PL195703B1 (pl) * 1997-09-09 2007-10-31 Hoffmann La Roche Zastosowanie polipeptydowego analogu peptydu pokrewnego hormonowi przytarczyc
ATE392431T1 (de) * 1998-05-05 2008-05-15 Sod Conseils Rech Applic Pth2 rezeptor selektive verbindungen
AU3826899A (en) * 1998-07-20 2000-02-14 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Peptide analogues of pacap
US6660843B1 (en) † 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
AU2000265051A1 (en) * 2000-02-18 2001-08-27 Dabur Research Foundation Vasoactive intestinal peptide analogs
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
CA2446929C (en) * 2001-06-01 2013-04-09 Novartis Ag Orally administering parathyroid hormone and calcitonin
JP4837888B2 (ja) * 2001-07-23 2011-12-14 ザ ジェネラル ホスピタル コーポレイション コンホメーションが拘束された副甲状腺ホルモン（ｐｔｈ）類似体
WO2005016265A2 (en) * 2003-08-06 2005-02-24 Rhodia Inc. Method for promoting bone growth
JP2009515535A (ja) 2005-11-10 2009-04-16 ボード オブ コントロール オブ ミシガン テクノロジカル ユニヴァーシティー クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
ES2739459T3 (es) * 2006-10-03 2020-01-31 Radius Health Inc Una composición estable que comprende una proteína anabólica ósea, es decir un análogo de PTHrP y usos de la misma
MX2009003740A (es) * 2006-10-13 2009-04-22 Lilly Co Eli Pth pegilado como moduladores de receptor pth y usos de los mismos.
KR101661730B1 (ko) 2007-08-01 2016-10-04 더 제너럴 하스피탈 코포레이션 Ｇ―단백질 결합 수용체를 이용한 스크리닝 방법 및 관련 조성물
EP2411038B1 (de) 2009-03-27 2016-12-28 Van Andel Research Institute Parathryoidhormonpeptide und parathyroidhormonbezogene proteinpeptide sowie anwendungsverfahren dafür
WO2011071480A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
EP2568806B1 (de) 2010-05-12 2016-05-11 Radius Health, Inc. Therapiepläne
EP2569003B1 (de) 2010-05-13 2017-10-25 The General Hospital Corporation Parathyroidhormon-analoga und verwendungen davon
ES2550319T3 (es) 2010-09-28 2015-11-06 Radius Health, Inc Moduladores selectivos del receptor de andrógenos
EP3122426B1 (de) 2014-03-28 2023-01-18 Duke University Brustkrebsbehandlung mit selektiven östrogenrezeptormodulatoren
CN108135177B (zh) 2015-04-29 2021-06-01 雷迪厄斯制药公司 用于治疗癌症的方法
CN108025042A (zh) * 2015-07-06 2018-05-11 董正欣 PTHrP类似物的新型制剂
DK3474841T3 (da) 2016-06-22 2022-05-09 Ellipses Pharma Ltd Fremgangsmåder til behandling af ar+-brystkræft
ES2981967T3 (es) 2017-01-05 2024-10-14 Radius Pharmaceuticals Inc Formas polimórficas de RAD1901-2HCl
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
JP7473486B2 (ja) 2018-07-04 2024-04-23 ラジウス ファーマシューティカルズ，インコーポレイテッド Ｒａｄ１９０１－２ｈｃｌの多形形態

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
EP0293158A3 (de) * 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroide Hormon-Antagonisten
JPH03504201A (ja) * 1989-02-23 1991-09-19 ゲゼルシャフト・フュア・ビオテクノロギッシェ・フォルシュンク・ミット・ベシュレンクテル・ハフツング　（ゲー・ベー・エフ） Ｐｔｈ変種をコードするｄｎａ配列、ｐｔｈ変種、発現ベクター、細菌宿主、利用と治療用組成物
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
WO1993006846A1 (en) * 1991-10-10 1993-04-15 Pang Peter K T Parathyroid hormone analogues and use in osteoporosis treatment
US5434246A (en) * 1992-03-19 1995-07-18 Takeda Chemical Industries, Ltd. Parathyroid hormone derivatives
CA2098639A1 (en) * 1992-06-19 1993-12-20 K. Anne Kronis Bone stimulating, non-vasoactive parathyroid hormone variants
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
US5821225A (en) * 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
SG47043A1 (en) 1993-01-06 1998-03-20 Kinerton Ltd Ionic molecular conjugates of biodegradeble polyesters and bioactive polypeptides
WO1995002610A1 (en) * 1993-07-13 1995-01-26 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
WO1996019246A1 (en) * 1994-12-19 1996-06-27 Beth Israel Hospital Association Continuous low-dose administration of parathyroid hormone or its agonist
CA2178894A1 (en) * 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone

Also Published As

Publication number Publication date
KR100497709B1 (ko) 2005-06-23
KR20000069952A (ko) 2000-11-25
CA2276614C (en) 2002-06-11
ES2347154T3 (es) 2010-10-26
CZ301497B6 (cs) 2010-03-24
AU5519998A (en) 1998-08-03
EP1645566B1 (de) 2010-06-16
US5955574A (en) 1999-09-21
AR011517A1 (es) 2000-08-30
BR9714200A (pt) 2000-03-28
KR100699422B1 (ko) 2007-03-28
EP0948541A2 (de) 1999-10-13
KR20060030006A (ko) 2006-04-07
NO993341L (no) 1999-09-06
HUP9904596A1 (hu) 2000-06-28
NZ336610A (en) 2001-07-27
WO1998030590A9 (en) 1999-08-19
DK1645566T3 (da) 2010-09-27
DE69735603T2 (de) 2006-11-30
CN1254347A (zh) 2000-05-24
ATE321784T1 (de) 2006-04-15
WO1998030590A3 (en) 1998-12-10
EP1645566A2 (de) 2006-04-12
HUP9904596A3 (en) 2000-07-28
CZ298937B6 (cs) 2008-03-19
SI1645566T1 (sl) 2010-11-30
PT948541E (pt) 2006-07-31
JP2001508439A (ja) 2001-06-26
EP0948541B1 (de) 2006-03-29
EP1645566A3 (de) 2006-10-11
JP3963482B2 (ja) 2007-08-22
DE69739912D1 (de) 2010-07-29
CN1137898C (zh) 2004-02-11
EP2206725A1 (de) 2010-07-14
ATE471342T1 (de) 2010-07-15
RU2198182C2 (ru) 2003-02-10
CA2276614A1 (en) 1998-07-16
IL130794A0 (en) 2001-01-28
SI0948541T1 (sl) 2006-06-30
HK1026215A1 (en) 2000-12-08
PT1645566E (pt) 2010-08-31
CZ239899A3 (cs) 2000-01-12
AU741584B2 (en) 2001-12-06
ES2258286T3 (es) 2006-08-16
NO993341D0 (no) 1999-07-06
PL191898B1 (pl) 2006-07-31
PL334438A1 (en) 2000-02-28
AR051906A2 (es) 2007-02-14
AR038552A2 (es) 2005-01-19
WO1998030590A2 (en) 1998-07-16
DK0948541T3 (da) 2006-07-17

Similar Documents

Publication Publication Date Title
DE69735603D1 (de) PTHrP Analogen
DE69638025D1 (de) Parathyroidhormon Analoge
NZ527053A (en) Modified amyloid precursor protein polynucleotides and polypeptides
EA199901025A1 (ru) Пептидные аналоги паратиреоидного гормона
IL210454A (en) Antibody against a new ligand of cytokine 17zcytor
BR9713294A (pt) "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano"
ATE354584T1 (de) Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungen
EA200001071A1 (ru) Способ получения полимер-связанных циклических пептидов
AU1447600A (en) Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
TR199700714A2 (xx) Paratiroit hormonu, analoglar�n�n sentezi i�in bir y�ntem.
DK0812856T3 (da) Fremgangsmåde til fjernelse af N-terminalt methionin
DK0427863T3 (da) DNA, som koder for protein, som kan kombinere med forstærker for alfa-fetoprotein-gen
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
DK0923644T3 (da) G-koblet receptor, der udviser selektiv selektivitet for ATP
DK0982399T3 (da) Thyroidhormontransportörer, agonister og antagonister deraf

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: IPSEN PHARMA S.A.S., BOULOGNE-BILLANCOURT, FR